Discussion

Cellectis bioresearch, subsidiary of Cellectis group, provides genome customization products and services to Life Science researchers. Based on in-field expertise and proprietary technologies, Cellectis bioresearch enables precise modifications of DNA sequences in a target genome, whether it is a cell line, a primary cell or a stem cell. Cellectis bioresearch brings to the bench engineered cell lines and cellular models with the desired characteristics for optimal relevance and performance.
Using site-specific nucleases, the genome of the cell can be engineered to create a knock-out, a knock-in, or to edit the sequence of a desired gene.
Our proprietary technology is robust and highly effective at developing relevant models for disease studies.